• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: January 18-22, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

January 18-22, 2010

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs1/20/10Silver Spring, MDAfia AsamoahLyle Beckwith, Doug Kantor, Jim Barnette, John Manthei (National Association of Convenience Stores)Retail Segment of the Tobacco Industry
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs1/21/10Silver Spring, MDAfia Asamoah, Ann Witt, Uros Djekic, Diane Maloney, Jane Axelrad, Tracey Forfa, Carolyn Becker, Michael ChappellAaron Lyss (American Association of Blood Banks ); Richard Carnevale (Animal Health Institute); Andrew Emmett (Biotechnology Information Organization); Gordon Johnston, Ashlee Konce (Generic Pharmaceutical Association); Jeffrey Francer, Alan Goldhammer, Jennifer Stotka (Pharmaceutical Research and Manufacturers of America); Bridget Rossiter Elis (Plasma Protein Therapeutics Association)Transparency Listening Session
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs1/21/10Silver Spring, MDN/ANav Singh, Vivian Riefberg, Nick Lovegrove (McKinsey and Company)Collaboration with FDA
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health1/19/10Washington, D.C.Vicki Seyfert-MargolisSeveral participants from Private Industry, Government and AcademiaPCAST National Nanotechonology Meeting
Russell Abbott, Deputy Commissioner for Administration1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget1/21/10Washington, DCN/ASeveral members of the American Health Lawyers AssociationFDA and the Public Health
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health1/18/10-
1/22/10
N/AN/AN/ANo Signicant Meetings
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition1/20/10-
1/21/10
Phoeniz, ArizonaN/AN/AInternational Dairy Foods Association Forum
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine1/22/10Washington, D.C.William Flynn, Cindy BurnsteelRich Carnevale (Animal Health Institute)Veterinary issues of mutual interest
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research1/20/10-
1/21/10
Jefferson, ARN/AN/AU.S. Nutritional Phenotype Database Training Workshop
Ralph Tyler, J.D., Chief Counsel1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings 
Lawrence Deyton, M.D., M.P.H., Director, Center for Tobacco Products1/18/10-
1/22/10
N/AN/AN/ANo Significant Meetings